Restoring Veeva Systems to Watch List

With Q1 sales growth of almost 24%, Veeva has returned to the Green Screens and will return to the Watch List as well. This specialized pharmaceutical SaaS provider continues to have an outstanding economic moat, and growth is re-accelerating after a few slow years. My fair value estimate is $186. The stock trades a touch below that at present, making this one a close watch for Buy List addition in the near future.

Watch List

APPF 4.30%
CMG 40.33%
PSTG -1.39%
WDAY -5.41%
VEEV 19.23%
INTU 20.20%
RDDT 16.57%
NTNX 27.22%
CRWD 95.83%
SE 32.72%
SNOW 13.92%

Buy List

PINS -38.24%
SEMR -33.68%
TSM -40.25%
ZETA -27.44%
GOOG -50.34%
NYAX -30.24%
MSFT -28.00%
FLYW -39.29%
HRMY -59.63%
YOU -39.80%
ABNB -31.51%
ADBE -41.68%

Hold List

ASML -23.91%
VTEX -13.76%
ODD -6.91%
ASR -24.09%
CELH 39.84%
TOST 18.60%
CPNG -11.81%
HIMS -5.43%
PAYC -18.56%
MNDY 21.64%
GLBE -21.93%
ZS 38.75%
V -4.82%
ADSK 1.57%
NOW 15.34%
MELI -19.68%
FTNT 1.73%
TEAM 0.14%